Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter L Collins

Showing results (191-200 of 247) with videos related to

Pageof 25
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|March 20, 2013
Neonatal antibody responses are attenuated by interferon-γ produced by NK and T cells during RSV infectionJohn S Tregoning, Belinda Lei Wang, Jacqueline U McDonald, et al.
Journal of Clinical Microbiology|December 21, 2012
Phylogenetic and pathotypic characterization of newcastle disease viruses circulating in west Africa and efficacy of a current vaccineArthur Samuel, Baibaswata Nayak, Anandan Paldurai, et al.
Virology|June 6, 2006
Attenuating mutations in the P/C gene of human parainfluenza virus type 1 (HPIV1) vaccine candidates abrogate the inhibition of both induction and signaling of type I interferon (IFN) by wild-type HPIV1William Van Cleve, Emerito Amaro-Carambot, Sonja R Surman, et al.
Journal of Virology|January 18, 2019
Effects of Alterations to the CX3C Motif and Secreted Form of Human Respiratory Syncytial Virus (RSV) G Protein on Immune Responses to a Parainfluenza Virus Vector Expressing the RSV G ProteinBo Liang, Barbora Kabatova, Juraj Kabat, et al.
Journal of Virology|April 14, 2005
RhoA signaling is required for respiratory syncytial virus-induced syncytium formation and filamentous virion morphologyTara L Gower, Manoj K Pastey, Mark E Peeples, et al.
The Journal of Clinical Investigation|July 14, 2015
Aerosolized Ebola vaccine protects primates and elicits lung-resident T cell responsesMichelle Meyer, Tania Garron, Ndongala M Lubaki, et al.
Hepatology (Baltimore, Md.)|May 10, 2014
Long-term outcome in patients with severe alcoholic hepatitis can be reliably determined using an in vitro measure of steroid sensitivityAshwin D Dhanda, Alex J di Mambro, Vicky L Hunt, et al.
Virology|June 27, 2002
Sendai virus, a murine parainfluenza virus type 1, replicates to a level similar to human PIV1 in the upper and lower respiratory tract of African green monkeys and chimpanzeesMario H Skiadopoulos, Sonja R Surman, Jeffrey M Riggs, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 27, 2014
Attenuation of human respiratory syncytial virus by genome-scale codon-pair deoptimizationCyril Le Nouën, Linda G Brock, Cindy Luongo, et al.
Genome Announcements|February 14, 2013
Complete genome sequence of an avian paramyxovirus type 4 from north america reveals a shorter genome and new genotypeManoharan Parthiban, Manimaran Kaliyaperumal, Sa Xiao, et al.
Pageof 25

Showing results (191-200 of 247) with videos related to

Sort By:
Pageof 25
Proceedings of the National Academy of Sciences of the United States of America|March 20, 2013
Neonatal antibody responses are attenuated by interferon-γ produced by NK and T cells during RSV infectionJohn S Tregoning, Belinda Lei Wang, Jacqueline U McDonald, et al.
Journal of Clinical Microbiology|December 21, 2012
Phylogenetic and pathotypic characterization of newcastle disease viruses circulating in west Africa and efficacy of a current vaccineArthur Samuel, Baibaswata Nayak, Anandan Paldurai, et al.
Virology|June 6, 2006
Attenuating mutations in the P/C gene of human parainfluenza virus type 1 (HPIV1) vaccine candidates abrogate the inhibition of both induction and signaling of type I interferon (IFN) by wild-type HPIV1William Van Cleve, Emerito Amaro-Carambot, Sonja R Surman, et al.
Journal of Virology|January 18, 2019
Effects of Alterations to the CX3C Motif and Secreted Form of Human Respiratory Syncytial Virus (RSV) G Protein on Immune Responses to a Parainfluenza Virus Vector Expressing the RSV G ProteinBo Liang, Barbora Kabatova, Juraj Kabat, et al.
Journal of Virology|April 14, 2005
RhoA signaling is required for respiratory syncytial virus-induced syncytium formation and filamentous virion morphologyTara L Gower, Manoj K Pastey, Mark E Peeples, et al.
The Journal of Clinical Investigation|July 14, 2015
Aerosolized Ebola vaccine protects primates and elicits lung-resident T cell responsesMichelle Meyer, Tania Garron, Ndongala M Lubaki, et al.
Hepatology (Baltimore, Md.)|May 10, 2014
Long-term outcome in patients with severe alcoholic hepatitis can be reliably determined using an in vitro measure of steroid sensitivityAshwin D Dhanda, Alex J di Mambro, Vicky L Hunt, et al.
Virology|June 27, 2002
Sendai virus, a murine parainfluenza virus type 1, replicates to a level similar to human PIV1 in the upper and lower respiratory tract of African green monkeys and chimpanzeesMario H Skiadopoulos, Sonja R Surman, Jeffrey M Riggs, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 27, 2014
Attenuation of human respiratory syncytial virus by genome-scale codon-pair deoptimizationCyril Le Nouën, Linda G Brock, Cindy Luongo, et al.
Genome Announcements|February 14, 2013
Complete genome sequence of an avian paramyxovirus type 4 from north america reveals a shorter genome and new genotypeManoharan Parthiban, Manimaran Kaliyaperumal, Sa Xiao, et al.
Pageof 25